Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
The Food and Drug Administration (FDA) is alerting emergency medicine and surgery professionals of serious adverse events that may result from the long-term use of inferior vena cava (IVC) filters. IVC filters are a type of catheter that is implanted into the inferior vena cava, a large vein that carries de-oxygenated blood from the lower half of the body into the right atrium of the heart, to prevent fatal pulmonary emboli.
Foreign particle contamination of several products used to treat rare, serious and life-threatening diseases has prompted a warning by the Food and Drug Administration (FDA). The warning includes products made by Genzyme and marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme and Thyrogen – used to treat serious conditions such as Gaucher Disease and thyroid cancer. The foreign particles found in the medications include stainless steel fragments, non-latex rubber from the vial stopper, and fiber-like material from the manufacturing process, and could potentially cause serious adverse events in patients.
All lots and expiration dates of 65 BodyBuilding.com brand dietary supplements are being recalled because the Food and Drug Administration (FDA) believes the products contain ingredients that are either classified or the FDA believes they should be classified as steroids. Acute liver injury is known to be a possible harmful effect of using steroid-containing products.
Steroids also may cause other serious long-term adverse health consequences including shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.
The Food and Drug Administration (FDA) has issued a warning to health care professionals to use extreme caution when prescribing Qualaquin (Quinine Sulfate), according to the Postmarket Reviews section of the Volume 2, Number 2 2, 2009 issue of its quarterly online newsletter, Drug Safety News (DSN).
![[ Beasley Allen Law Firm Logo ]](http://www.southerninjurylawyer.com/wp-content/themes/system-unity/images/logo.png){kind=logo}